ESSA Pharma to Present at JMP Securities Life Sciences Conference

SOUTH SAN FRANCISCO, California and VANCOUVER, Canada, May 11, 2023 /CNW/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the JMP Securities Life Sciences Conference on Tuesday, May 16, 2023 at 10:00 a.m. Eastern Time in New York.

David R. Parkinson, President and Chief Executive Officer of ESSA Pharma; Peter Virsik, ESSA's Chief Operating Officer; and David S. Wood, ESSA's Chief Financial Officer, will host and participate in one-on-one meetings.

A live webcast of the JMP Securities presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the event, the webcast will be archived on the ESSA website for 90 days.

ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.

View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-jmp-securities-life-sciences-conference-301821736.html

SOURCE ESSA Pharma Inc

View original content: http://www.newswire.ca/en/releases/archive/May2023/11/c8725.html